
    
      The oxyhydrogen generator with nebulizer in (treatment group) or control group was applied
      randomly for the patients with severe asthma in this study, then the therapeutic effects from
      both treatment and control groups were analyzed and evaluated to verify its safety and
      effectiveness.This study is a multi-center, randomized, double-blind study. Each patient was
      expected to participate in the trial for 104±3 day.The screening period was 14±1 days, and
      the subjects would continue to be applied with the previous asthma treatment scheme. The
      primary objective was to collect the baseline data related to the subjects.The patients would
      receive 30±1 day of treatment with the product; after that, observation of 60±1 days was
      required.Total patients number is 150 cases, of which 75 cases are treatment group and the
      others are control group.All cases respectively are distributed in 5 clinical hospitals.
    
  